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ABSTRACT 
 
At present, there is no cure for diabetes. However, due to the side effects of synthetic drugs, 
medicinal plants, have been variously used to treat it. One such anti-diabetic plant is chicory.  The 
aim of this study is to review and summarize the clinical aspects and mechanisms of the effects of 
chicory and its products on the key factors involved in diabetes in different environments. 
Accordingly, it seems chicory is effective in almost all tissues and organs involved in blood sugar 
control. For instance, chicory has been shown to (i) inhibit the breakdown of disaccharides in the 
gastrointestinal tract and glucose absorption in the intestine, (ii) prevent the release of glucose 
from the liver, (iii) increase glucose uptake by the peripheral tissues, especially in muscles and the 
liver, (iv) stimulate insulin secretion from the pancreas, (v) enhance the insulin signaling pathways 
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downstream and thereby reduce the diabetic complications. Consequently, blood glucose 
reduction after the administration of chicory is notable. The administration of chicory products 
appeared to have short-term and/or long-term effects on diabetes. This claim is approved by the 
results from the glucose tolerance test and HbA1c measurement. In addition, chicory fights against 
some primary agents responsible for diabetes and obesity. Since chicory reduces blood glucose 
and it has anti-diabetic effects, it is recommended that the involved mechanisms be investigated. 
 
 
Keywords: Diabetes; chicory; blood sugar; insulin. 
 
1. INTRODUCTION 
 
A major concern of clinicians is that patients with 
type 2 diabetes have increased substantially in 
recent years. Currently, about 180 million people 
worldwide suffer from the disease. The number 
of people with type 2 diabetes is increasing with 
a rate of three new cases every 10 seconds and 
the figure is expected to reach 325 million by 
2025 [1,2]. Although there are many medications 
to control blood sugar, these drugs often cause 
side effects such as edema, weight gain, and 
heart failure [3]; patients often seek additional 
suitable remedies from among anti-diabetic 
herbal extracts. Cichorium intybus L. 
(Asteraceae) is one of the most important 
medicinal plants and there has been a lot of 
interest in this regard [4]. Cichorium intybus L. 
(chicory) has been used in traditional medicine to 
treat a variety of conditions such as high blood 
sugar [5]. Currently, chicory and its products are 
used to treat a range of diseases. All parts of the 
plant (roots, leaves and seeds) are anti-allergic, 
anti-bacterial, anti-ulcerative, anti-inflammatory, 
appetizer, digestive, tonic and diuretic [4,6,7]. 
However, most important of all, chicory is known 
for its having hypoglycemic and hypolipidemic 
properties [8]. 
The possible mechanism of the hypoglycemic 
effect of chicory can be through enhancing 
insulin secretion from beta cell islands or due to 
increased glucose transport into cells in 
peripheral tissues or inhibiting glucose 
absorption in the intestine or by other 
mechanisms such as inhibiting endogenous 
glucose production through the gluconeogenesis 
and glycogenesis pathways [9]. In the figure 
below, there is a schematic summary of the 
mechanisms of anti-diabetic effects of chicory on 
different organs and tissues in the body (see   
Fig. 1). 
 
Some reports suggest that ethanolic extract can 
decrease serum glucose by reducing the activity 
of hepatic glucose-6-phosphatase [10]. Chicoric 
Acid, an active gradient of chicory leaves, 
increases the release of insulin from pancreatic 
beta cells and glucose uptake by cultured muscle 
cells [11]. These are some examples of the 
mechanisms and beneficial effects of chicory on 
diabetes discovered until now. However, it 
seems that no comprehensive study and 
review in connection with the anti-diabetic effects 
of chicory have been conducted yet. 
 
 
 
 
Fig. 1. A summary of the potential effects of chicory and products on different body organs or 
tissues of a person with diabetes 
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2. CHICORY EFFECTS ON THE 
GASTROINTESTINAL TRACT 
 
Chicory has a long history of herbal use and, in 
particular, has great value for tonic effects on the 
liver and digestive tract. The roots and leaves are 
appetizer, digestive, laxative, hepatoprotective 
and tonic  [6,12]. It seems the tonic properties of 
chicory may be useful for the treatment of 
diarrhea [6]. The chicory alcoholic extract is used 
for the treatment of pyuria (the presence of pus 
in the urine) [13]. 
 
Aqueous extract of chicory seed contains 
significant amounts of sucrose and an 
oligosaccharide include fructose and glucose 
[14,15]. However, these findings are in contrast 
with a lot of sugar found in the extract [14]; in 
streptozotocin-induced diabetic rats have shown 
that oral administration of chicory extract just 30 
minutes before the test improves glucose 
tolerance test. According to the studies, it seems 
that the effect of chicory on the percentage of 
serum glucose reduction is much stronger than 
metformin [10]. Studies have shown that 
normal rats after the injection of the aqueous 
extract of chicory in jejunum reduced the glucose 
absorption [16]. Therefore, it seems that chicory 
may have the potential effect in reducing 
hyperglycemia after a meal [10] . 
 
Inulin is a polymer of the fructose present in the 
chicory [10]; in fact, the main composition of 
chicory roots [17]. Since this compound is water-
soluble and is not digested by the human 
digestive enzymes, it possesses the 
hypolipidemic effect like soluble fibers [18,19]. 
Soluble fibers are non-digestible which 
fermented by anaerobic bacteria and the 
mechanism by which soluble fibers apply their 
hypolipidemic effects is still not clear, as many 
theories have been proposed in this field [20,21]. 
However, the observed changes in blood sugar 
caused by chicory or inulin were reversible after 
switching to a fiber-free perfusate [17]. In 
addition, a significant reduction in serumic 
triglycerides and cholesterol levels in rats treated 
with insulin [21], chicory extract [16] or soluble 
fibers [22] has been reported. All of these studies 
suggest that the effects may be due to the 
presence of inulin [10]. However, in some studies 
the effects of chicory containing smaller amounts 
of inulin in improving bowel movements have 
been proven [23]. 
 
In another study conducted by Jurgoński et al. 
[15], some complications of metabolic syndrome, 
such as hyperglycemia, triglyceridemia and 
increased blood serum atherogenicity were 
induced experimentally in rats. This diet also 
causes increase in intestinal sucrase activity and 
some impaired process such as production of 
short-chain fatty acids. However, the extract 
reduced the intestinal sucrase activity in these 
animals [15]. In this study, the extract of chicory 
seed decreased the serum concentration of 
glucose to observed levels in normal control 
group. The glycemia-lowering mechanism of the 
extract seems to be, at least in part, the 
consequence of local effects of chicory in the 
gastrointestinal tract. It was also reported that 
chlorogenic acid as one of the organic 
compounds contained in chicory might have an 
antagonistic effect on the intestinal glucose 
transporter [24]. Moreover, inhibition of α-
glucosidase activity caused by the extract of 
chicory seed is attributed to some triterpenoids 
[25]. 
 
3. EFFECTS OF CHICORY ON SERUM 
BIOCHEMICAL MARKERS 
 
In 2010, the effects of chicory on blood 
parameters in diabetic rats were studied by 
Ghamarian A et al. [14]. Late stage (severe) and 
early (mild) stage of Type 2 diabetes were 
induced in rats by injection of streptozotocin and 
a combination of STZ and niacinamide, 
respectively. Body weight, fasting blood sugar 
(FBS), glycosylated hemoglobin A1c(HbA1c), 
serum enzymes alanine aminotransferase (ALT) 
and aspartate aminotransferase (AST), nitric 
oxide (NO), triglycerides, total cholesterol, total 
protein and insulin levels on days 10 and 18 days 
after treatment were measured [14]. 
 
4. EFFECTS OF CHICORY ON SERUM 
BIOCHEMICAL MARKERS: BLOOD 
SUGAR 
 
According to the results of Ghamarian A et al. 
study, during the three weeks of treatment, 
induction of severe and mild diabetes in rats 
increased FBS about 3.5 and 1.8-fold, 
respectively. While the chicory treated diabetic 
rats were able to resist excessive increases in 
FBS. An overall comparison of the groups 
suggested that chicory helped prevent the 
increase of blood glucose in both mild and 
severe diabetic rats [14]. 
 
While HbA1c had almost doubled in severe 
diabetic rats, chicory administration reduced 
HbA1c and FBS during this period; however, 
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these two parameters were still higher than 
normal. A slight reduction of HbA1c in diabetic 
rats treated with chicory indicated that the blood 
sugar levels remained relatively low following the 
administration of chicory. Because of the lack of 
insulin in severe diabetes, the assessment on 
blood parameters indicates that chicory may also 
work through insulin-independent mechanisms. 
Based on the results achieved from glucose 
tolerance test (GTT) and HbA1c, in general, it 
seems that chicory has short-term and long-term 
effects on diabetes. From these results, it seems 
that chicory may be a useful natural food 
supplement to improve the diabetes condition or 
delay the development of diabetes and its 
complications [14].  
 
It has been recently shown that acute 
administration of chicory extract (500 mg/kg) 
significantly reduced blood glucose levels and 
this effect remained active for up to 6 hours. The 
decrease in the chronic daily treatment with 
chicory was substantially higher than the acute 
treatment [26]. Some studies indicate that the 
chronic administration of chicory extract causes 
the elimination of glucose and ketone bodies 
traces that were present in the urine of 
experimental induced diabetic rats before 
treatment [9]. According to Pourfarjam et al. 
(2015), however, it seems that chicory has no 
significant effect on the expression sodium-
glucose transporters in the kidney (SGLT-1 and 
SGLT-2) [27]. Based on the obtained results, it is 
clear that the elimination of glucose and ketone 
bodies traces could be due to a decrease in 
blood glucose caused by various reasons. 
 
As mentioned above, several mechanisms may 
be involved in anti-hyperglycemic effects of 
chicory. However, among these mechanisms, the 
ability to inhibit the activity of the enzyme 
glucose-6-phosphatase in the liver can not be 
ignored. Glucose-6-phosphatase as a key 
determinant of the glucose production catalyzes 
the terminal step in the release of glucose from 
the liver and it plays a key role in blood glucose 
homeostasis. It is demonstrated that the activity 
of this enzyme is increased in diabetic patients 
[28,29]. 
 
Pushparaj et al. results showed that the activity 
of glucose-6-phosphatase in the liver of diabetic 
rats were significantly higher than normal rats but 
its activity significantly decreased by chicory-rich 
diet [10]. The lowered activity of this enzyme is 
associated with decreased serum glucose; that's 
because less glucose was being produced and 
released into the blood stream [10]. 
 
5. EFFECTS OF CHICORY ON SERUM 
BIOCHEMICAL MARKERS: INSULIN 
 
In the study of Ghamarian et al.  [14], chicory 
effects on blood insulin levels in mild diabetic rats 
were more obvious than the severe group, after 
the induction of experimental diabetes, since the 
number of pancreatic beta cells in mild diabetic 
rats had been still remained for the production 
and secretion of insulin, whereas plasma insulin 
concentrations in the severe diabetic rats before 
and after treatment with chicory was about zero. 
However, this effect was not observed in some 
other studies, which can be the same with the 
severe diabetic group in the study of Ghamarian 
et al., due to highly destruction of pancreatic beta 
cells [30]. In fact, the destruction of beta cells by 
streptozotocin administration in the pancreatic 
islets of rats induces insulin-dependent diabetes 
mellitus [31]. Thus, the ability of the extracts to 
reduce blood glucose levels in severe diabetic 
rats (almost have no insulin), further 
substantiates an insulin-independent and extra 
pancreatic mode of action of the chicory [26]. In 
support of the above observations, in the study of 
Pushparaj et al. [10], despite a significant 
decrease in blood glucose levels, no significant 
changes were observed in the serum insulin of 
all groups. In fact, in this case, anti-
hyperglycemic activity of chicory is not through 
the insulin secretion [26]. 
 
A number of in-vitro studies have attempted to 
investigate the effects of chicory upon insulin 
secretion. The in-vitro studies give us more 
confidence in the ability of some compounds 
present in chicory to stimulate insulin secretion. 
In such studies, the results of in-vitro study of the 
effects of chicoric acid (CRA) and chlorogenic 
acid (CGA) isolated from chicory on insulin 
secretion in glucose-responsive and insulin 
secreting pancreatic β-cell line INS-1 and also 
the pancreatic islets isolated from rats as 
expected suggest that CRA and CGA only in the 
presence of high concentrations of glucose (8.3 
mM), increase significantly insulin secretion [32]. 
 
Studies have shown that the mechanism by 
which the compounds stimulate insulin secretion 
is different from that of sulfonylurea drugs [32]; 
moreover, the sulfonylurea drugs can also 
increase insulin secretion even in the absence of 
hyperglycemia, which potentially leads to 
hypoglycemia and can also cause some side 
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effects [33,34]. The present data show that, in 
contrast to sulfonylureas, CRA and CGA are 
ineffective on insulin secretion from isolated 
islets under low glucose concentration (2.8 mM) 
and their insulinotropic effects occur at 
intermediate glucose concentration. In addition, 
the insulinotropic ability of these compounds will 
be enhanced by increasing the glucose 
concentration [32]. 
 
Experimental studies on the effects of chicory on 
insulin are not restricted to its ability to stimulate 
insulin secretion; in most cases, chicory ability to 
reduce insulin resistance and improve its effects 
on peripheral tissues have been proven. In the 
study of Ghamarian et al., the comparison of 
GTT plots for mild diabetic rats may suggest a 
relative improvement of insulin sensitivity and in 
the chicory-treated group. According to the 
papers, the alleviation of hyperinsulinemia 
together with the decrease of ALT activity in the 
chicory-treated mild diabetic rats suggest an 
amelioration of insulin resistance [14,35]. 
 
In the study, the change in the peak insulin time 
point in chicory-treated mild diabetic group 
compared to its control (60 minutes versus 90 
minutes) indicates that pancreatic beta cells 
respond quicker to postprandial hyperglycemia 
and further support insulinotropic ability of 
chicory. However, the same effect was not 
observed in mild diabetic rats; that is probably 
due to the lack of insulin in the severe diabetics. 
It can be inferred that chicory plays a key role as 
insulin-sensitizer and in the case of severe 
diabetic rats which receive exogenous insulin 
should also be able to act [14]. To investigate 
this hypothesis, Nowrouzi et al who had 
previously demonstrated the effects of chicory on 
mild diabetic mice (in a joint study by Ghamarian 
and Nowrouzi), examined these effects in 
another small study [27]. In the study, the effect 
of chicory extract on glucose tolerance test in the 
presence and absence of exogenous insulin in 
the severe diabetic rats (with highly destructed 
pancreatic beta-cells) was examined [36]. The 
results showed that the administration of 
exogenous insulin lowered blood glucose, but the 
chicory extract exhibited synergistic effects in 
lowering blood glucose. These results indicate 
that the glucose-lowering effect of chicory 
mainly relies on the presence of insulin; in type 2 
diabetes, chicory acts as an insulin sensitizer 
that leads to the alleviation of insulin resistance 
in target organs [36]. 
 
6. EFFECTS OF CHICORY ON SERUM 
BIOCHEMICAL MARKERS: LIPIDS 
 
Diabetic conditions are often associated with 
increased levels of blood sugar and lipids along 
with the lipoprotein disorders [37]. It is well 
known that insulin activates the enzyme 
lipoprotein lipase, and thereby hydrolyzes blood 
triacylglycerols [38]. Destruction of pancreatic 
beta cells leads to depletion of plasma insulin, 
which causes hyperlipidemia. Furthermore, 
diabetes mellitus due to increase in 
triacylglycerols, LDL and decrease in HDL and in 
fact increase in cholesterol is associated with the 
risk of atherosclerosis [39]. Similarly, the results 
of studies indicate that the experimental 
induction of diabetes in rats, increases serum 
levels of lipids such as triglycerides and 
cholesterol [26]. It was recently shown that the 
administration of chicory extract to diabetic rats 
alleviates serum cholesterol and triglyceride 
levels [9]. This effect may be due to a decrease 
in the activity of cholesterol biosynthesis 
enzymes or decreasing the rate of lipolysis which 
are under the control of insulin [40]. 
 
In the study of Ghamarian et al., in the mild 
diabetic rats, the main variations included slight 
increases in TG. After chronic daily treatment 
with chicory, the TG  levels decreased to the 
normal range [14]. Significant and remarkable 
control of plasma lipid concentrations caused by 
chicory extract may be due to amelioration of 
insulin secretion [9]. However, the severe       
lack   of insulin did not stop long-term positive 
effects of chicory on blood parameters in 
experimental induced severe diabetic rats [14]. 
Moreover, decrease in plasma triglycerides and 
cholesterol in this group may be a secondary 
response       to amelioration of lipid metabolism 
[14,35], and inhibition of adipogenesis [41]. Of 
course, similar to blood sugar, the administration 
of chicory did not produce any 
significant changes in lipid levels in the serum of 
normal rats [10,14]. 
 
It can be concluded that Chicory effects on lipid 
parameters in diabetic rats are similar to those 
caused by the injection of insulin. As in the study 
of Kaskoos RA et al. (2012), similar to chicory 
treatment, insulin restored the altered lipid 
parameters such as total cholesterol, LDL, HDL, 
VLDL and triglycerides in STZ-induced diabetic 
rats significantly closer to normal ranges. And 
also chicory has been shown to decrease        
the atherogenic index significantly [26]. The 
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atherogenic index represents the ratio of LDL 
and VLDL to HDL [42]. 
 
7. EFFECTS OF CHICORY ON SERUM 
BIOCHEMICAL MARKERS: PLASMA 
NO 
 
Insulin resistance is usually associated with 
impaired nitric oxide (NO), so that endothelial NO 
(eNO) synthesis is reduced in subjects with type 
2 diabetes [43,44]. Because NO inhibits protein 
tyrosine phosphatase-1 B (PTP-1B) after 
entering the muscle and fat cells, and thereby 
enhances the effects of insulin (see Fig. 2) 
[45,46]. In addition, it directly increases glucose 
uptake by enhancing the translocation of vesicles 
containing glucose transporter-4 (GLUT-4) [46-
48]. In the study of Ghamarian et al., STZ-
induced experimental diabetes was associated 
with a significant reduction in serum NO; while, 
treatment with chicory extract prevented the 
reduction of NO [14].  In addition to the beneficial 
effects on improving insulin resistance (since NO 
is also an important player in the nervous 
system), chicory may provide a beneficial role in 
the prevention of neurological complication of 
diabetes [49]. 
 
8. EFFECTS OF CHICORY ON SERUM 
BIOCHEMICAL MARKERS: NON-
FUNCTIONAL PLASMA ENZYMES 
 
Usually an increase in the activity of enzymes 
ALT and AST in serum is considered a sensitive 
indicator of the liver disease; but several studies 
have shown that high levels of serum ALT 
activity and the increase of ALT/AST ratios are 
associated with insulin resistance and metabolic 
syndrome [35,50,51]. In this study, Ghamarian et 
al., experimental diabetes induced by 
streptozotocin was associated with significant 
increase in serum ALT activities which were 
lowered significantly by chronic daily oral 
administration of chicory; this confirmed the 
properties of chicory to protect the liver, improve 
metabolic syndrome and insulin resistance. The 
results confirm the benefit of chicory in the 
treatment and prevention of metabolic syndrome 
and insulin resistance [14]. 
 
9. EFFECTS OF CHICORY ON INSULIN 
SIGNALING PATHWAY 
 
Under normal conditions, the rate-limiting step of 
glucose metabolism is the transport of glucose 
into muscle and adipose cells, that is regulated 
physiologically by insulin dependent and 
independent signaling pathways which rely on 
GLUT4 vesicles translocation to the plasma 
membrane [52]. The major pathological changes 
in patients with type 2 diabetes include a relative 
deficiency in insulin secretion and progressive 
development of insulin resistance leading to 
hyperglycemia [53]. The general consensus is 
that insulin resistance is due to a defect in one or 
more of the cascades of insulin signaling in 
insulin-responsive tissues such as skeletal 
muscle, fat and liver which quantitatively 
constitute the major consumers of glucose in 
the body [54]. 
 
Under normal circumstances, insulin binds to its 
trans-membrane receptor tyrosine kinase on the 
cell surface which results in receptor auto-
phosphorylation and the tyrosine 
phosphorylation of insulin receptor substrate 
family of proteins [55]. Within the insulin signaling 
cascade, it is clear that the activation 
of phosphatidylinositol 3-kinase (PI3K) by insulin 
receptor substrate (IRS) is essential, for insulin is 
necessary in order to induce Glut4 translocation 
and glucose uptake through the channels                 
[56-58]. 
 
On the other hand, insulin-dependent glucose 
uptake is downregulated by protein tyrosine 
phosphatases (PTPs). It is clear that under 
normal and diabetic conditions, protein tyrosine 
phosphatases play a key role in cellular signaling 
pathways. Among the several protein tyrosine 
phosphatases, PTP-1B appears to be a key 
modulator of insulin signaling transduction which 
affects components, such as IRS1 and PI3K (see 
Fig. 2) [59]. 
 
PTP-1B as an intracellular phosphatase in the 
insulin signaling cascade is capable to 
dephosphorylate and thus inactivate insulin 
receptor (IR) and also IRS [60,61]. The 
phosphatase, due to its central role and 
significance in governing the adipogenesis and 
insulin signaling has emerged as a potential 
target for diabetes and obesity [62]; so that 
overexpression of PTP-1B in obesity-related 
insulin resistance has been reported [63]. A fine 
balance between kinases involved in the insulin 
downstream signaling (such as IRTK) and the 
phosphatases (such as PTP-1B) is necessary to 
a normal physiological condition. Moreover, for 
the improvement of insulin resistance, it is 
required to shut down the signals that are caused 
by PTP-1B [59]. However, it has been proved 
that the discovery of effective PTP-1B inhibitors 
with selective properties is difficult [64] . 
 
Fig. 2. Insulin signal transduction
surface receptor; resulting in activation of receptor tyrosine kinases. Insulin 
receptor autophosphorylation and receptor
activation of enzyme PI3K. Activating
mediated steps resulting in GLUT4 translocation and glucose uptake increase in peripheral 
tissue cells such as muscle and fat. In addition, the
conditions appears in different ways can 
each of the proteins may be associated with insulin resistance and type 2 diabetes. Chicory 
extract may potentially enhance cell surface GLUT4 by mimic or reinforce the effects of each 
step, and thereby i
 
Muthusamy V et al. (2010) indicated that the 
incubation of 3T3L-1 cells with the chicory extract 
and chlorogenic acid (as one of the active 
compounds present in the chicory extract) 
resulted in significant increase in 2
glucose uptake. Extending to an in
the effect of chicory extract was also investigated 
on insulin sensitivity in experimentally induced 
type 2 diabetic rats, and it was found that feeding 
the rats with chicory extract for 2 we
sufficient to fully reinstate insulin 
this study, as the effect of this treatment, 
downstream effectors of insulin signaling 
pathway such as IR, PI3K, protein kinase B 
(PKB) and GLUT-4 were also significantly 
reinstated. In fact, the chicory extract may 
improve the insulin signal transduction pathway 
by increasing the expression of each of the 
markers [65]. However, the ability of chicory to 
influence PI3K-independent pathways have been 
proved previously [41]. 
 
10. CONCLUSION  
 
The administration of chicory products appeared 
to have short-term and long-term effects on 
Nowrouzi et al.; AJRIMPS, 1(4): 1-11, 2017; Article no.
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 pathways initiated by insulin binding to its cell 
-mediated IRS-1 phosphorylation followed by 
 the last enzyme through a series of enzyme
 entry of NO into the cells under normal 
reinforce insulin signaling cascade. Dysfunction of 
mprove the diabetic condition 
-deoxy 
-vivo model, 
eks might be 
sensitivity. In 
diabetes. This claim is approved by the results 
from the glucose tolerance test and HbA1c
measurement. Possible mechanism of the 
hypoglycemic effect of chicory can be through 
enhancing insulin secretion from beta cell islands 
or due to increased glucose transport into cells in 
peripheral tissues or inhibiting 
absorption in the intestine or by other 
mechanisms such as inhibiting endogenous 
glucose production through the gluconeogenesis 
and glycogenesis pathways. Thus, it is 
suggested comprehensive studies be conducted 
in connection with the anti-diabetic
of chicory. Also, it seems that the effect of 
chicory on the percentage of serum glucose 
reduction is much stronger than some of anti
diabetic drugs that are recommended to be 
investigated through comparative assessments.
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